China
· Delayed Price · Currency is CNY Humanwell Healthcare (Group) Co.,Ltd. Statistics
Total Valuation
Humanwell Healthcare (Group) Co.,Ltd. has a market cap or net worth of CNY 37.45 billion. The enterprise value is 45.34 billion.
| Market Cap | 37.45B |
| Enterprise Value | 45.34B |
Important Dates
The next estimated earnings date is Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | Oct 11, 2024 |
Share Statistics
Humanwell Healthcare (Group) Co.,Ltd. has 1.61 billion shares outstanding. The number of shares has increased by 1.27% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.61B |
| Shares Change (YoY) | +1.27% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 9.97% |
| Owned by Institutions (%) | 24.07% |
| Float | 986.95M |
Valuation Ratios
The trailing PE ratio is 19.54 and the forward PE ratio is 16.07. Humanwell Healthcare (Group) Co.,Ltd.'s PEG ratio is 1.79.
| PE Ratio | 19.54 |
| Forward PE | 16.07 |
| PS Ratio | 1.47 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | 31.44 |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.79 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.65, with an EV/FCF ratio of 38.07.
| EV / Earnings | 23.19 |
| EV / Sales | 1.77 |
| EV / EBITDA | 10.65 |
| EV / EBIT | 12.72 |
| EV / FCF | 38.07 |
Financial Position
The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.45.
| Current Ratio | 1.49 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 2.23 |
| Debt / FCF | 7.98 |
| Interest Coverage | 10.00 |
Financial Efficiency
Return on equity (ROE) is 12.99% and return on invested capital (ROIC) is 7.38%.
| Return on Equity (ROE) | 12.99% |
| Return on Assets (ROA) | 6.01% |
| Return on Capital (ROIC) | 7.38% |
| Revenue Per Employee | 1.45M |
| Profits Per Employee | 110,628 |
| Employee Count | 17,676 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 3.74 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.34% in the last 52 weeks. The beta is 0.84, so Humanwell Healthcare (Group) Co.,Ltd.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -16.34% |
| 50-Day Moving Average | 21.14 |
| 200-Day Moving Average | 19.90 |
| Relative Strength Index (RSI) | 54.95 |
| Average Volume (20 Days) | 23,424,616 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Humanwell Healthcare (Group) Co.,Ltd. had revenue of CNY 25.56 billion and earned 1.96 billion in profits. Earnings per share was 1.19.
| Revenue | 25.56B |
| Gross Profit | 11.87B |
| Operating Income | 3.56B |
| Pretax Income | 3.27B |
| Net Income | 1.96B |
| EBITDA | 4.23B |
| EBIT | 3.56B |
| Earnings Per Share (EPS) | 1.19 |
Balance Sheet
The company has 4.76 billion in cash and 9.50 billion in debt, giving a net cash position of -4.74 billion or -2.95 per share.
| Cash & Cash Equivalents | 4.76B |
| Total Debt | 9.50B |
| Net Cash | -4.74B |
| Net Cash Per Share | -2.95 |
| Equity (Book Value) | 21.02B |
| Book Value Per Share | 11.18 |
| Working Capital | 6.76B |
Cash Flow
In the last 12 months, operating cash flow was 2.49 billion and capital expenditures -1.30 billion, giving a free cash flow of 1.19 billion.
| Operating Cash Flow | 2.49B |
| Capital Expenditures | -1.30B |
| Free Cash Flow | 1.19B |
| FCF Per Share | 0.74 |
Margins
Gross margin is 46.44%, with operating and profit margins of 13.94% and 7.65%.
| Gross Margin | 46.44% |
| Operating Margin | 13.94% |
| Pretax Margin | 12.78% |
| Profit Margin | 7.65% |
| EBITDA Margin | 16.57% |
| EBIT Margin | 13.94% |
| FCF Margin | 4.66% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 1.32%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 1.32% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 56.19% |
| Buyback Yield | -1.27% |
| Shareholder Yield | 0.05% |
| Earnings Yield | 5.12% |
| FCF Yield | 3.18% |
Stock Splits
The last stock split was on July 22, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Jul 22, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Humanwell Healthcare (Group) Co.,Ltd. has an Altman Z-Score of 2.84. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.84 |
| Piotroski F-Score | n/a |